229E-HCoV-HR1P

General Information


DRACP ID  DRACP03984

Peptide Name   229E-HCoV-HR1P

Sequence  AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ

Sequence Length  56

UniProt ID  P15423 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C251H410N74O88S

Absent amino acids  CEPRWY

Common amino acids  ANQT

Mass  688578

Pl  5.49

Basic residues  3

Acidic residues  3

Hydrophobic residues  22

Net charge  0

Boman Index  -7946

Hydrophobicity  -13.93

Aliphatic Index  88.93

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  20

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29415501

Title  Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains

Doi Not available

Year  2018

Literature 2

Pubmed ID 30989115

Title  A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15165

DRACP is developed by Dr.Zheng's team.